Bond Gilead Biosciences Inc 0.75% ( US375558BW29 ) in USD
| Issuer | Gilead Biosciences Inc |
| Market price | 100 % ▲ |
| Country | United States
|
| ISIN code |
US375558BW29 ( in USD )
|
| Interest rate | 0.75% per year ( payment 2 times a year) |
| Maturity | 28/09/2023 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 1 000 USD |
| Total amount | 2 000 000 000 USD |
| Cusip | 375558BW2 |
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) |
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) |
| Detailed description |
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need, primarily focusing on HIV/AIDS, hepatitis B and C, and oncology. The Bond issued by Gilead Biosciences Inc ( United States ) , in USD, with the ISIN code US375558BW29, pays a coupon of 0.75% per year. The coupons are paid 2 times per year and the Bond maturity is 28/09/2023 The Bond issued by Gilead Biosciences Inc ( United States ) , in USD, with the ISIN code US375558BW29, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Gilead Biosciences Inc ( United States ) , in USD, with the ISIN code US375558BW29, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
Français
Italiano
United States